Luyao Chen

ORCID: 0000-0003-0469-1681
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal cell carcinoma treatment
  • Bladder and Urothelial Cancer Treatments
  • Renal and related cancers
  • Urinary and Genital Oncology Studies
  • Prostate Cancer Diagnosis and Treatment
  • Nanocomposite Films for Food Packaging
  • Renal and Vascular Pathologies
  • Urologic and reproductive health conditions
  • Postharvest Quality and Shelf Life Management
  • MicroRNA in disease regulation
  • Prostate Cancer Treatment and Research
  • Pelvic floor disorders treatments
  • Ferroptosis and cancer prognosis
  • Circular RNAs in diseases
  • Epigenetics and DNA Methylation
  • Polysaccharides Composition and Applications
  • Phytochemicals and Antioxidant Activities
  • Ureteral procedures and complications
  • Polysaccharides and Plant Cell Walls
  • Kidney Stones and Urolithiasis Treatments
  • Urological Disorders and Treatments
  • Esophageal Cancer Research and Treatment
  • Cancer Genomics and Diagnostics
  • Pediatric Urology and Nephrology Studies
  • Multiple and Secondary Primary Cancers

First Affiliated Hospital of Nanchang University
2017-2025

Nanchang University
2017-2025

China Agricultural University
2022-2025

Jiangsu Agri-animal Husbandry Vocational College
2025

First Affiliated Hospital of Jiangxi Medical College
2024

Mayo Clinic
2024

Beijing Forestry University
2024

Southern Medical University
2020-2023

Second Military Medical University
2022

Hangzhou Normal University
2022

Abstract Objectives To compare the efficiency and safety of a novel flexible ureteral access sheath (f-UAS) traditional (UAS) during retrograde intrarenal surgery (RIRS). Patients methods Between January 2022 September 2022, total 152 consecutive cases with renal stones underwent RIRS f-UAS. Their outcomes were compared those another undergoing UAS using 1:1 scenario matched-pair analysis, matching parameters including age stone size. The f-UAS is 10-cm-long tube at tip that can follow bends...

10.1007/s00345-023-04697-1 article EN cc-by World Journal of Urology 2024-01-04

We compared treatment outcomes of robotic vs open inferior vena cava thrombectomy for renal tumors with level I-II tumor thrombus.We retrospectively reviewed the medical records patients who underwent or between 2006 and 2016. To reduce inherent biases a nonrandomized study groups were matched 1:1 based on key variables. Perioperative data oncologic reviewed. Progression-free overall survival was analyzed using Kaplan-Meier curves log rank test.A total 31 37 thrombectomy, respectively. After...

10.1016/j.juro.2017.06.094 article EN The Journal of Urology 2017-07-08

The aim of this study is to investigate the trends in incidence and mortality, explore any change survival penile cancer United States.

10.3389/fonc.2022.891623 article EN cc-by Frontiers in Oncology 2022-06-17

Increased expression of CCL18 has been observed in various malignancies and the urine samples patients with bladder cancer (BC). However, roles development, progression metastasis BC remain unclear. The present study demonstrated that was significantly associated advanced clinical stages BC. Furthermore, exogenous promoted cell invasion migration, induced epithelial‑mesenchymal transition (EMT) cells. Western blotting E‑cadherin, an epithelial marker, decreased, whereas matrix...

10.3892/mmr.2018.9791 article EN cc-by-nc-nd Molecular Medicine Reports 2018-12-24

Celecoxib, a selective cyclooxygenase‑2 inhibitor, has chemo‑preventive activity against different cancer types, including bladder (BC). However, the mechanisms by which celecoxib exerts its preventative effects have yet to be completely understood. In present study, effect of on epithelial‑to‑mesenchymal transition (EMT) BC cells and potential molecular were investigated. The results study demonstrated that inhibited proliferation, migration, invasion EMT cells. Further investigation...

10.3892/ijmm.2019.4241 article EN cc-by-nc-nd International Journal of Molecular Medicine 2019-06-12

Ferroptosis is a non-apoptotic form of cell death driven by iron-dependent lipid peroxidation. Recent evidence indicates that inhibiting ferroptosis could alleviate cerebral ischemia/reperfusion (CIR) injury. γ-glutamylcysteine (γ-GC), an intermediate glutathione (GSH) synthesis, can upregulate GSH in brains. the co-factor peroxidase 4 (GPX4), which negative regulator ferroptosis. In this study, we explored effect γ-GC on CIR-induced neuronal and brain We found significantly reduced volume...

10.3390/antiox11091653 article EN cc-by Antioxidants 2022-08-25
Coming Soon ...